Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM1KGS7)

• Drug Name: Tesofensine Drug Info
• Synonyms: NS-2330

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 11370864
  CAS Number: CAS 195875-84-4
  TTD Drug ID: DM1KGS7

Molecule-Related Drug Atlas

Drug(s) Targeting Insulin receptor (INSR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Meglitinides	DM1OFHN	Type-2 diabetes	5A11	Approved	[3]
Human neutral insulin	DMA5OBU	Diabetic complication	5A2Y	Approved	[4]
Insulin Lyspro recombinant	DM5XHVR	Diabetic complication	5A2Y	Approved	[4]
Insulin, porcine	DMO95XI	Diabetic complication	5A2Y	Approved	[5]
Insulin recombinant	DMYVP5G	Diabetic complication	5A2Y	Approved	[4]
Metformin arginine-hemisuccinimide	DMTPAM3	Type-2 diabetes	5A11	Approved	[6]
Insulin-lispro	DM4O90W	Diabetic complication	5A2Y	Approved	[7]
Insulin-glulisine	DMQI0FU	Diabetic complication	5A2Y	Approved	[8]
Ryzodeq	DMOFP18	Type-2 diabetes	5A11	Approved	[9]
NN5401	DM0QV27	Diabetic complication	5A2Y	Phase 3	[9]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Insulin receptor (INSR)	TTCBFJO	INSR_HUMAN	Inhibitor	[2]

References

• [1] ClinicalTrials.gov (NCT00153010) An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type. U.S. National Institutes of Health.
• [2] The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. Eur J Pharmacol. 2010 Jun 25;636(1-3):88-95.
• [3] New drugs for type 2 diabetes mellitus: what is their place in therapy Drugs. 2008;68(15):2131-62.
• [4] Knockouts model the 100 best-selling drugs--will they model the next 100 Nat Rev Drug Discov. 2003 Jan;2(1):38-51.
• [5] Acidic residues on the N-terminus of proinsulin C-Peptide are important for the folding of insulin precursor. J Biochem. 2002 Jun;131(6):855-9.
• [6] Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. Biochem Pharmacol. 2004 Jun 1;67(11):2081-91.
• [7] Hope for insulin mimetic oral antidiabetic drugs. Eur J Endocrinol. 1999 Dec;141(6):561-2.
• [8] Insulin glulisine: a review of its use in the management of diabetes mellitus. Drugs. 2009;69(8):1035-57.
• [9] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1800).